Tomoki Chiba
Impact in
- Molecular Biology top 0.2%
- Ubiquitin and proteasome pathways
- Genomics, phytochemicals, and oxidative stress
- Glutathione Transferases and Polymorphisms
- Bone Metabolism and Diseases
- Mitochondrial Function and Pathology
- Cell Biology top 0.1%
- Endoplasmic Reticulum Stress and Disease
Papers in
-
- NF-κB Signaling Pathways 13
-
- Ubiquitin and proteasome pathways 65
- RNA modifications and cancer 10
- Cancer-related gene regulation 9
- RNA Research and Splicing 9
- Co-authors
- Keiji TanakaShigeo MurataKazuhiko IgarashiMasaaki KomatsuTakashi UenoEiki KominamiIsei TanidaJunichi Iwata
- Journals
- Journal of Biological Chemistry (15 papers)Biochemical and Biophysical Research Communications (12 papers)The EMBO Journal (5 papers)Nature (5 papers)Scientific Reports (4 papers)
- Partner nations
- JapanUnited StatesGermany
In The Last Decade
Tomoki Chiba
140 papers receiving 20.4k citations
Hit Papers
Peers
Comparison fields: 5 of 153
- Molecular Biology 13.7k
- Cell Biology 3.2k
- Aging 308
- Epidemiology 5.7k
- Neurology 2.0k
Countries citing papers authored by Tomoki Chiba
This map shows the geographic impact of Tomoki Chiba's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Tomoki Chiba with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Tomoki Chiba more than expected).
Fields of papers citing papers by Tomoki Chiba
This network shows the impact of papers produced by Tomoki Chiba. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Tomoki Chiba. The network helps show where Tomoki Chiba may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Tomoki Chiba, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 1 | |
| 2 | 2022 | 1 | |
| 3 | 2022 | 44 | |
| 4 | Cartilage Homeostasis and Osteoarthritis Hit paper breakdown → | 2022 | 126 |
| 5 | 2022 | 7 | |
| 6 | 2017 | 17 | |
| 7 | SCF Fbl12 increases p21 Waf1/Cip1 expression level through atypical ubiquitin chain synthesis | 2016 | 1 |
| 8 | 2015 | 26 | |
| 9 | 2010 | 4 | |
| 10 | 2008 | 23 | |
| 11 | 2007 | 452 | |
| 12 | スペックルタイプPOZ蛋白質(SPOP)を含むBTBドメインはCul3に基づくユビキチンリガーゼによるユビキチン化Daxxアダプターとして働く | 2006 | 2 |
| 13 | 2006 | 17 | |
| 14 | Impairment of starvation-induced and constitutive autophagy in Atg7 -deficient mice Hit paper breakdown → | 2005 | 1941 |
| 15 | 2005 | 60 | |
| 16 | 2005 | 61 | |
| 17 | 2004 | 64 | |
| 18 | 2002 | 63 | |
| 19 | 2001 | 183 | |
| 20 | 1993 | 60 |
About Tomoki Chiba
Tomoki Chiba is a scholar working on Cancer Research, Molecular Biology, Cell Biology, Immunology and Oncology, having authored 141 papers that have together received 20.7k indexed citations. Recurring topics across this work include Ubiquitin and proteasome pathways (65 papers), Endoplasmic Reticulum Stress and Disease (17 papers), NF-κB Signaling Pathways (13 papers), Autophagy in Disease and Therapy (13 papers), Cancer-related Molecular Pathways (11 papers), RNA modifications and cancer (10 papers), Cancer-related gene regulation (9 papers) and RNA Research and Splicing (9 papers). The work is most often cited by research in Molecular Biology (13.7k citations), Cell Biology (3.2k citations), Aging (308 citations), Epidemiology (5.7k citations) and Neurology (2.0k citations). Tomoki Chiba has collaborated with scholars based in Japan, United States and Germany. Frequent co-authors include Keiji Tanaka, Shigeo Murata, Kazuhiko Igarashi, Masaaki Komatsu, Takashi Ueno, Eiki Kominami, Isei Tanida, Junichi Iwata, Yasuo Uchiyama and Satoshi Waguri. Their work appears in journals such as Journal of Biological Chemistry, Biochemical and Biophysical Research Communications, The EMBO Journal, Nature and Scientific Reports.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.